81 FR 28086 - National Institute on Drug Abuse; Notice of Closed Meetings

DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health

Federal Register Volume 81, Issue 89 (May 9, 2016)

Page Range		28086-28086
FR Document		2016-10779

Federal Register, Volume 81 Issue 89 (Monday, May 9, 2016)

[Federal Register Volume 81, Number 89 (Monday, May 9, 2016)]
[Notices]
[Page 28086]
From the Federal Register Online  [www.thefederalregister.org]
[FR Doc No: 2016-10779]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


National Institute on Drug Abuse; Notice of Closed Meetings

    Pursuant to section 10(d) of the Federal Advisory Committee Act, as 
amended (5 U.S.C. App), notice is hereby given of the following 
meetings.
    The meetings will be closed to the public in accordance with the 
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 
U.S.C., as amended. The grant applications and the discussions could 
disclose confidential trade secrets or commercial property such as 
patentable material, and personal information concerning individuals 
associated with the grant applications, the disclosure of which would 
constitute a clearly unwarranted invasion of personal privacy.

    Name of Committee: National Institute on Drug Abuse Special 
Emphasis Panel; Seek, Test, Treat and Retain For Youth and Young 
Adults Living with or at High Risk for Acquiring HIV (R01).
    Date: May 17, 2016.
    Time: 8:00 a.m. to 5:00 p.m.
    Agenda: To review and evaluate grant applications.
    Place: The Residence Inn, Washington DC Downtown, 1199 Vermont 
Ave. NW., Washington, DC 20005.
    Contact Person: Nadine Rogers, Ph.D., Scientific Review Officer, 
Office of Extramural Policy and Review, National Institute on Drug 
Abuse, NIH, DHHS, 6001 Executive Blvd., Room 4229, MSC 9550, 
Bethesda, MD 20892-9550, 301-402-2105, [email protected].
    This notice is being published less than 15 days prior to the 
meeting due to the timing limitations imposed by the review and 
funding cycle.

    Name of Committee: National Institute on Drug Abuse Special 
Emphasis Panel; Identification of Genetic and Genomic Variants by 
Next-Gen Sequencing in Non-human Animal Models (U01).
    Date: June 17, 2016.
    Time: 8:00 a.m. to 5:00 p.m.
    Agenda: To review and evaluate cooperative agreement 
applications.
    Place: Bethesda North Marriott Hotel & Conference Center, 5701 
Marinelli Road, Bethesda, MD 20852.
    Contact Person: Jagadeesh S. Rao, Ph.D., Scientific Review 
Officer, Office of Extramural Policy and Review, National Institute 
on Drug Abuse, National Institutes of Health, DHHS, 6001 Executive 
Boulevard, Room 4234, MSC 9550, Bethesda, MD 02892, 301-443-9511, 
[email protected].

(Catalogue of Federal Domestic Assistance Program Nos.: 93.279, Drug 
Abuse and Addiction Research Programs, National Institutes of 
Health, HHS)

    Dated: May 3, 2016.
Natasha M. Copeland,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2016-10779 Filed 5-6-16; 8:45 am]
 BILLING CODE 4140-01-P

28086 Federal Register / Vol. 81, No. 89 / Monday, May 9, 2016 / Notices

OS specifically requests comments on Date: June 17, 2016. SUPPLEMENTARY INFORMATION:
(1) the necessity and utility of the Time: 8:00 a.m. to 5:00 p.m. Technology description follows.
proposed information collection for the Agenda: To review and evaluate Title of invention: Optical trap
cooperative agreement applications. methods to determine the viscoelastic
proper performance of the agency’s
Place: Bethesda North Marriott Hotel &
functions, (2) the accuracy of the properties of complex materials,
Conference Center, 5701 Marinelli Road,
estimated burden, (3) ways to enhance Bethesda, MD 20852. including biological materials
the quality, utility, and clarity of the Contact Person: Jagadeesh S. Rao, Ph.D., Description of Technology: Optical
information to be collected, and (4) the Scientific Review Officer, Office of traps (optical tweezers) have been used
use of automated collection techniques Extramural Policy and Review, National to characterize gels and other materials
or other forms of information Institute on Drug Abuse, National Institutes and recently have even shown the
technology to minimize the information of Health, DHHS, 6001 Executive Boulevard, ability to characterize the viscoelastic
collection burden. Room 4234, MSC 9550, Bethesda, MD 02892, properties of living cells. An optical trap
301–443–9511, jrao@nida.nih.gov. includes a focused laser beam able to
Darius Taylor, trap a small bead at its focus. However,
(Catalogue of Federal Domestic Assistance
Information Collection Clearance Officer. Program Nos.: 93.279, Drug Abuse and issues of image spatial resolution and
[FR Doc. 2016–10775 Filed 5–6–16; 8:45 am] Addiction Research Programs, National limited depth of interrogation have
BILLING CODE 4168–11–P Institutes of Health, HHS) prevented application of an optical trap
Dated: May 3, 2016. to measure microrheological (flow of
Natasha M. Copeland, matter) properties in complex (non-
DEPARTMENT OF HEALTH AND uniform) materials, such as multi-
Program Analyst, Office of Federal Advisory
HUMAN SERVICES Committee Policy. cellular systems or living organisms.
[FR Doc. 2016–10779 Filed 5–6–16; 8:45 am] Inventors at NIH have developed
National Institutes of Health optical trapping procedures that provide
BILLING CODE 4140–01–P
National Institute on Drug Abuse; significant improvements in spatial
Notice of Closed Meetings resolution and tissue depth. These
DEPARTMENT OF HEALTH AND improvements are particularly
Pursuant to section 10(d) of the HUMAN SERVICES important for examining clinically
Federal Advisory Committee Act, as relevant tissue samples. The viscoelastic
amended (5 U.S.C. App), notice is National Institutes of Health measurements obtained using the
hereby given of the following meetings. disclosed systems and methods have a
The meetings will be closed to the Government-Owned Inventions; surprisingly high contrast-to-noise ratio
public in accordance with the Availability for Licensing compared to prior methods of obtaining
provisions set forth in sections viscoelastic measurements for complex
AGENCY: National Institutes of Health.
552b(c)(4) and 552b(c)(6), Title 5 U.S.C., materials. The increased contrast-to-
as amended. The grant applications and ACTION: Notice.
noise ratio allows for more sensitive
the discussions could disclose SUMMARY: The invention listed below is detection of changes in viscoelastic
confidential trade secrets or commercial owned by an agency of the U.S. properties across materials than what
property such as patentable material, Government and is available for was possible using prior methods. Thus,
and personal information concerning licensing and/or co-development in the the disclosed systems and methods can
individuals associated with the grant U.S. in accordance with 35 U.S.C. 209 be used to measure the properties of a
applications, the disclosure of which and 37 CFR part 404 to achieve wide variety of complex materials (such
would constitute a clearly unwarranted expeditious commercialization of as biological materials), from 3D tissue
invasion of personal privacy. results of federally-funded research and culture models to tissue in or from
Name of Committee: National Institute on development. Foreign patent living zebrafish to mammals, such as
Drug Abuse Special Emphasis Panel; Seek, applications are filed on selected mice and humans.
Test, Treat and Retain For Youth and Young inventions to extend market coverage Potential Commercial Applications:
Adults Living with or at High Risk for for companies and may also be available • Microrheological measurements can
Acquiring HIV (R01). increase knowledge of the cancer
Date: May 17, 2016.
for licensing and/or co-development.
ADDRESSES: Invention Development and
microenvironment.
Time: 8:00 a.m. to 5:00 p.m. • Diagnosis and/or treatment of a
Agenda: To review and evaluate grant Marketing Unit, Technology Transfer
condition or disease associated with
applications. Center, National Cancer Institute, 9609
Place: The Residence Inn, Washington DC tissue/cell remodeling, including tumor
Medical Center Drive, Mail Stop 9702,
Downtown, 1199 Vermont Ave. NW., state.
Rockville, MD, 20850–9702.
Washington, DC 20005. • Determine the effectiveness of a
FOR FURTHER INFORMATION CONTACT: particular compound or treatment or
Contact Person: Nadine Rogers, Ph.D.,
Scientific Review Officer, Office of Information on licensing and co- regimen (e.g cosmetic products for
Extramural Policy and Review, National development research collaborations, reducing wrinkles, scarring, etc.).
Institute on Drug Abuse, NIH, DHHS, 6001 and copies of the U.S. patent • Evaluate wound healing.
Executive Blvd., Room 4229, MSC 9550, applications listed below may be Value Proposition:
Bethesda, MD 20892–9550, 301–402–2105, obtained by contacting: Attn. Invention • Increased sensitivity in the
rogersn2@nida.nih.gov. Development and Marketing Unit,
This notice is being published less than 15
detection of changes in viscoelastic
Technology Transfer Center, National
mstockstill on DSK3G9T082PROD with NOTICES

days prior to the meeting due to the timing properties across materials.
limitations imposed by the review and Cancer Institute, 9609 Medical Center • Improvements in spatial resolution
funding cycle. Drive, Mail Stop 9702, Rockville, MD, and tissue depth.
Name of Committee: National Institute on 20850–9702, Tel. 240–276–5515 or • Localized, precise application of
Drug Abuse Special Emphasis Panel; email ncitechtransfer@mail.nih.gov. A force compared to magnetic bead
Identification of Genetic and Genomic signed Confidential Disclosure microrheology.
Variants by Next-Gen Sequencing in Non- Agreement may be required to receive • Greater dynamic range and can
human Animal Models (U01). copies of the patent applications. probe outside the thermal energy range

VerDate Sep<11>2014 17:44 May 06, 2016 Jkt 238001 PO 00000 Frm 00041 Fmt 4703 Sfmt 4703 E:\FR\FM\09MYN1.SGM 09MYN1

Document Created: 2018-02-07 14:49:56
Document Modified: 2018-02-07 14:49:56

Category		Regulatory Information
Collection		Federal Register
sudoc Class		AE 2.7: GS 4.107: AE 2.106:
Publisher		Office of the Federal Register, National Archives and Records Administration
Section		Notices
Dates		May 17, 2016.
FR Citation		81 FR 28086

81 FR 28086 - National Institute on Drug Abuse; Notice of Closed Meetings

DEPARTMENT OF HEALTH AND HUMAN SERVICESNational Institutes of Health

Federal Register Volume 81, Issue 89 (May 9, 2016)

DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health